- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02008669
Evaluation of Nutritional Status and Fatigue in Patients With Multiple Sclerosis (NUTRISEP)
Evaluation of the Nutritional Status of Patients With Multiple Sclerosis and Relationship With Fatigue
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Basse-Normandie
-
Caen, Basse-Normandie, France, 14033
- Centre Hospitalier Universitaire de Caen
-
-
Nord Pas-de-Calais
-
Arras, Nord Pas-de-Calais, France, 62022
- Centre Hospitalier d'Arras
-
Boulogne sur Mer, Nord Pas-de-Calais, France, 62200
- Centre Hospitalier de Boulogne, Hôpital Duchenne
-
Calais, Nord Pas-de-Calais, France, 62100
- Centre hospitalier de Calais
-
Lille, Nord Pas-de-Calais, France, 59000
- Groupement des Hôpitaux de l'Institut Catholique de Lille
-
Lille, Nord Pas-de-Calais, France, 59037
- Centre Hospitalier Regional Universitaire de Lille
-
Maubeuge, Nord Pas-de-Calais, France, 59600
- Centre Hospitalier de Sambre-Avenois
-
Raimbeaucourt, Nord Pas-de-Calais, France, 59283
- Centre Hélène Borel
-
Tourcoing, Nord Pas-de-Calais, France, 59208
- Centre Hospitalier Dron de Tourcoing
-
Valenciennes, Nord Pas-de-Calais, France, 59322
- Centre hospitalier de valenciennes
-
-
Nord-Pas De Calais
-
Douai, Nord-Pas De Calais, France, 59507
- Centre Hospitalier de Douai
-
-
Picardie
-
Amiens, Picardie, France, 80054
- Centre Hospitalier Universitaire d'Amiens
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients between 18 and 65 years old
- Expended disability status scale (EDSS) between 0 and 7
- Diagnosis of MS according to the revised criteria of McDonald
- Clinically stable patients in the past 3 months
- Coverage of the social insurance
- Informed consent to participate
Exclusion Criteria:
- Cognitive disorders that can hinder answering questionnaires
- Presence of uncontrolled metabolic disease(s)
- Malabsorption
- Patients with a gastrostomy
- Active cancer under treatment
- Anorexia
- Pregnancy or breast feeding
- Severe psychiatric disorder(s)
- No informed consent to participate
- No coverage by the social insurance
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Multiple Sclerosis cases
All patients will undergo the following interventions
|
A blood sample will be taken from each patient and the following parameters will be assessed : magnesium, albumin, Vitamin B12, Vitamin D, Calcium, Iron.
16 Taste Strips impregnated with 4 flavors (sweet, sour, salty, bitter, each flavor present at 4 different concentrations), are offered to the patient one after the other in a so-called pseudorandomized sequence. The task of the patient is to choose one of the following answers: sweet / sour / salty / bitter / no taste. Each correct answer is granted one point. In addition to the impregnated strips, two tasteless strips can be integrated in the examination at any point of time (no point) Evaluation of the following parameters by validated questionnaires (name of the questionnaire in bracket):
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correlation between the score of fatigue EMIF-SEP and the dosage of nutrients in blood (vitamins, minerals, proteins) adjusted by the EDSS status
Time Frame: Baseline
|
The objective is to construct and validate a regression model between the scale of fatigue and biological variables
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Presence or absence of sociodemographic variables
Time Frame: Baseline
|
Baseline
|
|
|
Presence or absence of clinical manifestations
Time Frame: Baseline
|
Baseline
|
|
|
Level of physical activity and daily energy expenditure
Time Frame: Baseline
|
Baseline
|
|
|
Assessment of dysphagia according to the score of the Dymus Test
Time Frame: Baseline
|
Baseline
|
|
|
Score of the taste sensibility test
Time Frame: Baseline
|
Baseline
|
|
|
Score of the Beck depression inventory test
Time Frame: Baseline
|
This test is a 21-question multiple-choice self-report inventory for measuring the severity of depression
|
Baseline
|
|
Score of the visual analog scale for the evaluation of sleep quality
Time Frame: Baseline
|
Baseline
|
|
|
Score of the Nutrition and Eating Habits Questionnaire
Time Frame: Baseline
|
Baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Cécile Donzé, MD, Groupement des Hôpitaux de l'Institut Catholique de Lille
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC-P0022
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Blood sampling
-
Institut du Cancer de Montpellier - Val d'AurelleRecruitingGlioma | Sarcoma | Cancer | Breast Cancer | Colon Cancer | Lung CancersFrance
-
Medical University of GrazJoanneum Research Forschungsgesellschaft mbHCompleted
-
CardioRenalCompletedPotassium MeasurementBelgium
-
Fondazione Policlinico Universitario Agostino Gemelli...Active, not recruiting
-
Assistance Publique - Hôpitaux de ParisURC Necker Cochin, FranceCompletedSepsis | Acute Circulatory FailureFrance
-
Centre Hospitalier Universitaire DijonCompletedPatients With Intellectual Disabilities Without an Obvious Clinical Diagnosis | Patients With Normal Array CGH and Previous Negative Genetic Investigations (WES-solo or WES-trio)France
-
Royal Surrey County Hospital NHS Foundation TrustCompletedThyroid Carcinoma | Thyroid Cancer | Cancer of the Thyroid | Cancer of ThyroidUnited Kingdom
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Rennes University HospitalCompletedMultiple SclerosisFrance
-
Institut PasteurSanofi Pasteur, a Sanofi Company; Institut Pasteur of Cote d'IvoireCompletedBordetella Pertussis, Whooping CoughCôte D'Ivoire